Director Declaration

GlaxoSmithKline PLC
13 July 2006



              GlaxoSmithKline plc Non-Executive Director's details


Further to the announcement dated 29 June 2006, the following details for Dr
Daniel Podolsky are provided in accordance with the requirements of the
Financial Services Authority's Listing Rules on his appointment to the Board of
GlaxoSmithKline plc with effect from 1 July 2006.

Dr Podolsky has not been a director of a publicly quoted company during the past
five years.  Neither does he hold or have any notifiable interests in any
GlaxoSmithKline plc Ordinary Shares or American Depositary Shares.

Paragraph 9.6.13 R (2) to (6) Financial Services Authority's Listing Rules

Dr Podolsky has no details to disclose in respect of paragraph 9.6.13 R (2) to
(6) of the Financial Services Authority's Listing Rules.



S M Bicknell
Company Secretary
13 July 2006



                      This information is provided by RNS
            The company news service from the London Stock Exchange